China

  • Located on Shanghai Chemical Industrial Park, Shanghai, China.
  • Fully integrated cGMP manufacturing site focused on production and supply of pharmaceutical intermediates and APIs
  • Modern design, inherent flexibility to address most API challenges
  • Analytical, QC capability for API release and sourced RM release
  • 10 reactors from 2500L to 8000L scale
  • Arranged as 4 segregated suites with capability to interlink
  • Dedicated filtration and drying for each reactor suite
  • Nominal batch sizes of 150kg to 630kg
  • Segregated solids handling and particle size reduction suite
  • Fully qualified process control and monitoring systems
  • On site bulk solvent storage and waste treatment facilities

Carbogen Amcis

News

11 August 2016
Dishman Celebrates a Decade of Success Since Acquisition of CARBOGEN AMCIS

2 February 2016
Dishman Netherlands awarded for its Corporate Social Responsibility.

24 September 2015
Dishman has been awarded manufacture of SIRTURO® (bedaquiline) API

9 February 2015
Successful FDA inspection at the Netherlands Dishman site

VIEW NEWS ARCHIVE